GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Haw Par Corp Ltd (OTCPK:HAWPF) » Definitions » Earnings per Share (Diluted)

Haw Par (Haw Par) Earnings per Share (Diluted)

: $0.73 (TTM As of Dec. 2023)
View and export this data going back to 2010. Start your Free Trial

Haw Par's Earnings per Share (Diluted) for the six months ended in Dec. 2023 was $0.38. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $0.73.

Haw Par's EPS (Basic) for the six months ended in Dec. 2023 was $0.38. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was $0.73.

Haw Par's EPS without NRI for the six months ended in Dec. 2023 was $0.38. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was $0.73.

During the past 12 months, Haw Par's average EPS without NRIGrowth Rate was 46.00% per year. During the past 3 years, the average EPS without NRIGrowth Rate was 21.70% per year. During the past 5 years, the average EPS without NRI Growth Rate was 0.70% per year. During the past 10 years, the average EPS without NRI Growth Rate was 2.80% per year.

During the past 13 years, Haw Par's highest 3-Year average EPS without NRI Growth Rate was 27.80% per year. The lowest was -17.50% per year. And the median was 4.80% per year.


Haw Par Earnings per Share (Diluted) Historical Data

The historical data trend for Haw Par's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Haw Par Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Earnings per Share (Diluted)
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.61 0.41 0.37 0.50 0.73

Haw Par Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Earnings per Share (Diluted) Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.19 0.25 0.24 0.35 0.38

Competitive Comparison

For the Drug Manufacturers - General subindustry, Haw Par's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Haw Par PE Ratio Distribution

For the Drug Manufacturers industry and Healthcare sector, Haw Par's PE Ratio distribution charts can be found below:

* The bar in red indicates where Haw Par's PE Ratio falls into.



Haw Par Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

Haw Par's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2023 is calculated as

Diluted Earnings Per Share (A: Dec. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(162.577-0)/221.368
=0.73

Haw Par's Earnings Per Share (Diluted) for the quarter that ended in Dec. 2023 is calculated as

Diluted Earnings Per Share (Q: Dec. 2023 )=(Net Income - Preferred Dividends / Shares Outstanding (Diluted Average)
=(84.4-0)/221.162
=0.38

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.73

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.


Haw Par  (OTCPK:HAWPF) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Haw Par Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of Haw Par's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Haw Par (Haw Par) Business Description

Traded in Other Exchanges
Address
401 Commonwealth Drive, No. 03-03 Haw Par Technocentre, Singapore, SGP, 149598
Haw Par Corp Ltd is a drug manufacturing company that operates multiple brands. The company is to expand its core businesses through product brand extension, strategic alliances, and exploring potential acquisitions. Its operating segments include the Healthcare segment, Investments segment, and Others segment. The company generates maximum revenue from the Healthcare segment. Its Healthcare segment manufactures and distributes topical analgesic products under the Tiger Balm and Kwan Loong brands. Geographically, it generates a majority of its revenue from the ASEAN countries.

Haw Par (Haw Par) Headlines

From GuruFocus

Haw Par Stock Is Believed To Be Significantly Overvalued

By GF Value GF Value 03-31-2021

First Eagle Comments on Haw Par

By Holly LaFon Holly LaFon 04-24-2018

Singapore Based Haw Par Selling at a Discount to NAV

By Holmes Osborne, CFA Holmes Osborne, CFA 07-26-2016